The Potential Effect of Insulin on AChE and Its Interactions with Rivastigmine In Vitro

There is no definite cure for Alzheimer’s disease (AD) due to its multifactorial origin. Drugs that inhibit acetylcholinesterase (AChE), such as rivastigmine, are promising symptomatic treatments for AD. Emerging evidence suggests that insulin therapy can hinder several aspects of AD pathology. Insu...

Descripción completa

Detalles Bibliográficos
Autores principales: Jamshidnejad-Tosaramandani, Tahereh, Kashanian, Soheila, Babaei, Mahsa, Al-Sabri, Mohamed H., Schiöth, Helgi B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617642/
https://www.ncbi.nlm.nih.gov/pubmed/34832918
http://dx.doi.org/10.3390/ph14111136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617642/
https://www.ncbi.nlm.nih.gov/pubmed/34832918
http://dx.doi.org/10.3390/ph14111136

Ejemplares similares